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1. INTRODUCTION 
CANCER   
Among the entire diseases, cancer ranks high as a major killer worldwide. Cancers are a 
large family of diseases that includes the abnormal cell growth with the potential to 
invade or spread to other parts of the body. The term cancer derives from the Greek word 
(Karkinoma) for crab, by Hippocrates used to describe the appendage-like projections 
extending from tumours. A tumor is any abnormal proliferation of cells, which may be 
either benign or malignant. Both benign and malignant tumor attacks surrounding normal 
tissue and spread throughout the body via the circulatory or lymphatic systems. Cancer 
refers to a disease of cells that show unlimited proliferation, dedifferentiation, 
invasiveness and the ability to metastasis .The branch of science dealing with the study 
of tumours or neoplasms is known as oncology. 
[1, 2]
 
The features are common to all types of cancer: 
 Abnormal cell growth 
 Capacity to invade other tissues 
 Capacity to spread to distant organs via blood vessels or lymphatic channels 
(metastasis) 
Cancers can be grouped into 5 main categories based on the type of cell they start in. 
 Carcinoma – cancer starts in the skin or in tissues that cover internal organs. 
There are a number of subtypes, including adenocarcinoma, basal cell 
carcinoma, squamous cell carcinoma, and transitional cell carcinoma 
 Sarcoma – cancer starts in the connective or supportive tissues such as bone, 
cartilage, fat, muscle, or blood vessels 
 Leukaemia – cancer that starts in blood forming tissue such as the bone 
marrow and causes large numbers of abnormal blood cells to be produced and 
go into the blood 
 Lymphoma and myeloma – cancers that begin in the cells of the immune 
system  
 Brain and spinal cord cancers – these are known as central nervous system 
cancers. 
[3] 
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PATHOPHYSIOLOGY 
[4] 
Cancers, occurs by a sequence of mutations, which causes the variation of the behavior 
of the cells. Normal cell mutated into cancer cells, reason for the failure of regulation of 
the cell growth and the carcinogenisis
 
 
 
                          
                                       Figure: 1 Pathophysiology of Cancer 
SIGNS AND SYMPTOMS 
A symptom is a signal that is felt or noticed by the person who has. It may not be 
easily seen. A sign is a signal that can be seen by the person.  
 Fatigue, fever 
 Weight changes( loss or gain) 
  Yellowing, darkening or redness of the skin, sores that won't heal, or changes to 
existing moles 
 Changes in bowel or bladder habits 
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 Bowels to anemia or rectal bleeding 
 Ulceration can cause bleeding    
 A persistent cough or trouble breathing 
 Esophageal cancer can cause narrowing of the esophagus difficulty swallowing 
 Hoarseness 
 Persistent indigestion or discomfort after eating 
 Persistent, unexplained muscle or joint pain 
 Unexplained bleeding or bruising [5] 
LIVER CANCER 
Liver cancer, also known as hepatic cancer or primary hepatic cancer. Cancer which has 
spread from another place to the liver is known as liver metastasis, is more common than 
that which starts in the liver. The major site of metabolism of ingested materials in liver, 
it is more susceptible to carcinogenic insult. Moreover, due to the high acceptance of 
liver, hepatocellular carcinoma is seldom detected at the early stage and once detected 
treatment has a poor prognosis in most cases. The liver can be affected by primary liver 
cancer that originates in the liver or by cancer which forms in other parts of the body and 
then spreads to the liver. The most common cause of liver cancer is cirrhosis which 
occurs due to hepatitis B, hepatitis C, or alcohol. The viruses induce malignant changes 
in the cells by affecting gene expression, altering gene methylation and repressing or 
promoting various cellular signal transduction pathways. Secondary liver cancer occurs 
as a result of metastasis of cancer from different parts of the body (intestine or pancreas) 
that drain into the liver via the portal vein or from other cancers. Liver cancer can also 
form from various other structures within the liver such as the blood vessels, bile duct 
and the immune cells. 
Liver cancers include: 
 Hepatocellular carcinoma (HCC) 
 Cholangiocarcinoma  
 
Cholangiocarcinoma refers to the cancer of the bile duct. The most frequent liver 
cancer which comprises 75% of all primary liver cancers is hepatocellular carcinoma.  
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Hepatocellular carcinoma is a cancer formed by the liver cells, called as hepatocytes 
that become malignant.  
The Hepatocellular carcinoma (HCC) is most common primary malignancy in liver 
and the third leading cause of cancer deaths worldwide, with few effective therapeutic 
options for this severe disease. HCC is associated with abdominal pain, abdominal mass, 
emesis, anaemia, jaundice and fever Most of the HCC appears in cirrhotic livers after 
years of chronic liver inflammation caused by hepatitis viral infection, alcoholic and 
non-alcoholic steatohepatitis. 
[6] 
LIVER CANCER RISK FACTORS: 
 Hepatitis B virus (HBV) 
 Hepatitis C virus (HCV) 
 Cirrhosis 
 Aflatoxin exposure 
 Heavy alcohol drinking 
 Tobacco 
 Smoking, Monogenic syndromes such as hereditary hemochromatosis and α-
1 antitrypsin deficiency. 
[7]
 
SYMPTOMS 
 Pain in the upper right part of your belly 
 A lump or feeling of heaviness in your upper belly 
 Bloating or swelling in your belly 
 Loss of appetite and feelings of fullness 
 Weight loss 
 Weakness or deep fatigue 
 Nausea and vomiting 
 Yellow skin and eyes 
 Pale, chalky bowel movements and dark urine 
 Fevers [8] 
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DIAGNOSIS 
 Abdominal CT scan 
 Abdominal ultrasound 
 Liver biopsy 
 Liver enzymes (liver function tests) 
 Liver MRI 
 Serum alpha fetoprotein [9] 
TYPES OF TREATMENT 
Primary liver cancer is rarely detectable early, when it is most treatable. Secondary or 
metastatic liver cancer is hard to treat because it has already spread. The liver's complex 
network of blood vessels and bile ducts makes surgery difficult. Most treatment concentrates 
on making patients feel better and perhaps live longer. 
 Patients with early-stage tumors that can be removed surgically have the best 
chance of long-term survival. 
 In some patients, chemotherapy is given directly into the liver 
(chemoembolization) to reduce tumors to a size that may make surgery possible.  
 Cryotherapy, or freezing the tumor, and radiofrequency ablation (RFA), using 
radio waves to destroy the tumor, may be used to treat some cases of liver cancer 
 A liver transplant may be an option for those with both liver cancer and cirrhosis. 
Although this procedure is risky, it offers some chance of long-term survival. 
[10]
 
PREVENTION 
 Preventing and treating viral hepatitis may help reduce your risk. Childhood 
vaccination against hepatitis B may reduce the risk of liver cancer in the future. 
 Do not drink excessive amounts of alcohol. 
 People with certain types of hemochromatosis (iron overload) may need to be 
screened for liver cancer. 
 People who have hepatitis B or C or cirrhosis may be recommended for liver 
cancer screening. 
[11]
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EXPERIMENTAL MODELS FOR HCC 
Several rodent models have been used in defining the pathogenesis of HCC and 
have contributed to the current knowledge of HCC. Because of the physiologic and 
genetic similarities between rodents and humans, the short lifespan and the breeding 
capacity, rodents are often used for cancer research. Many chemically induced 
experiments have been conducted on rats (Rattus norvegicus) but Mice (Mus musculus) 
are also a favourite model for cancer because of the availability of gene targeting 
methods and the possibility of xenograft implantation. A Broad range of models are 
available which mainly includes 
i. Chemically induced models 
ii. Transgenic models 
iii. Xenograft models 
CHEMICALLY INDUCED MODELS 
A few of the chemical compounds has been found to be carcinogens when 
administered in sufficient dose and given particular time span. They either belong to any 
of the two classes by the way which it induces tumor formation. 
i. Genotoxic compounds -   which are capable of inducing structural DNA changes, 
and  
ii. Promoting compounds - which lack direct genotoxic capability, but enhance 
tumour formation after initiation by a hepatotoxic compound. 
 
Chemical models of hepatocarcinogenesis often involve initiation by a carcinogen 
followed by a growth stimulus promoter to induce clonal expansion of initiated cells or 
by repeated administration of the carcinogen for a prlonged period of time.  
 
DIETHYLNITROSAMINE INDUCED HCC 
N-nitrosodiethylamine (DEN) is often used as a carcinogenic reagent. The 
carcinogenic capacity of DEN is situated in its capability of alkylating DNA structures. 
In the first step, DEN is hydroxylated to a-hydroxylnitrosamine. This bioactivation step  
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is oxygen-and NADPH-dependent and is mediated by cytochrome P450, an enzyme 
which has its highest activity in the centrilobular hepatocytes. After cleavage of 
acetaldehyde, an electrophilic ethyldiazonium ion is formed. This ethyldiazonium ion 
causes DNA damage by reacting with nucleophiles such as DNA-bases. Furthermore, 
oxidative stress caused by DEN can contribute to hepatocarcinogenesis.  DEN works in a 
dose dependent manner, a single low initiation dose does not lead to the formation of 
neoplasm; administration of a high dose induces HCC after a period of latency. The 
development of HCC after administration of DEN not only depends on the dose but also 
on several other factors such as age, sex and strain of the animal. The yonger animals are 
found to develop HCC faster due to its high hepatocyte proliferation rate. Male rats are 
found to show 100% development while female rats show only 30% of tumor 
development. This gender related difference is due to the inhibitory effect of estrogen 
and stimulating effect of androgens on hepatocarcinogenesis. The tumor sensitive rats 
are found to develop HCC fater than tumor resistant rat strains. 
[12] 
INFLAMMATION 
[13]
 
Inflammation is defined as the local response of living mammalian tissues to injury due 
to any foreign agent, in order to eliminate or limit the spread of injurious agent, followed 
by removal of the necrosed cells and tissues. 
The agents causing inflammation are: 
a) Infective agents like bacteria, viruses and their toxins, parasites, fungi. 
b) Immunological agents like cell-mediated and antigen antibody reactions. 
c) Physical agents like heat, cold, radiation, mechanical trauma. 
d) Chemical agents like organic and inorganic poisons. 
e) Inert materials such as foreign bodies 
AGENT CAUSING INFLAMMATION 
[14, 15]
 
 Infectious agent              : Bacteria, viruses and their toxins, fungi. 
 Immunological agent      : Cell mediated and antigen anti body reaction 
 Chemical agents             : Organic and inorganic poisons  
 Inert materials                 : Foreign bodies 
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SIGNS OF INFLAMMATION  
The inflammation was first described by Celsus who identified cardinal signs of 
inflammation as: 
 Rubor (Redness) 
 Tumor(Swelling) 
 Calor (Heat) 
 Dolor (Pain) 
 Function Laesa(Loss Of Function) 
Redness of inflammation is due to dilation of vascular bloods in injured area and heat is 
due to increased blood flow. Swelling occurs due to edema formation caused by fluid 
accumulation and plasma protein in the extra vascular spaces. Pain inflammation due to 
increased pressure in the tissue which leads to increased firing of pain afferents in 
affected area. 
MEDIATORS OF INFLAMMATION 
 Histamine 
 Prostaglandins 
 Leukotrienes 
 Serotonin 
 Lysosome 
 Platelet activation factors 
 Nitric oxide 
 Cytokines 
 Bradykinins 
PHASES OF INFLAMMATION 
[16] 
 Vasodilatation: Vasodilatation is the first phase of inflammation, caused by 
increase in vascular permeability result in exudation of fluid from blood into 
interstitial space  
 Exudation: Exudation is the second phase of inflammation; it involves the 
filtration of leukocytes from blood into tissue 
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 Emigration of cells: It is the third phase of inflammation; it involves granuloma 
migration and tissue repair. 
TYPES OF INFLAMMATION 
Based on the defense capacity of the host and duration of response, inflammation 
can be classified as acute and chronic 
A. Acute inflammation is of short duration, enduring less than 2 weeks and represents 
the early body reaction, resolves quickly and is usually followed by healing. 
The main features of acute inflammation are: 
I. Accumulation of fluid and plasma at the affected site. 
II. Intravascular activation of platelets. 
III. Polymorphonuclear neutrophils as inflammatory cells 
B. Chronic inflammation is of longer duration and occurs either after the causative 
agent of acute inflammation persists for a long time, or the stimulus is such that it 
induces chronic inflammation from the beginning. The characteristic feature of chronic 
inflammation is presence of chronic inflammatory cells such as lymphocytes, plasma 
cells and macrophages, granulation tissue formation, and in specific situations as 
granulomatous inflammation. 
[12] 
CAUSES OF INFLAMMATION 
 Microbial infections: Microbes include viruses, bacteria, protozoa, fungi and 
various parasites.  
 Hypersensitivity reactions 
 Physical agents, irritant and corrosive chemicals: Physical trauma, ultraviolet or 
other ionizing radiation, burns or excessive cooling ('frostbite') may cause  tissue 
damage leading to inflammation. Corrosive chemicals such as acids, alkalis, 
oxidizing agents are also inflammatory stimulus that can cause direct tissue 
damage. 
 Tissue necrosis: Lack of oxygen or nutrients results into inadequate blood flow 
and it is a potent inflammatory stimulus that can cause the death of tissues. 
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ROLE OF INFLAMMATION 
1) Physiological role 
- Eliminate cause of inflammation and to minimalize tissue damage 
- To stop spreading of the cause of inflammation  
- To activate processes of regeneration and repair 
- Without inflammation, the tissues are not capable of healing 
    2) Pathological role 
- Excessive or long-lasting reaction leading to tissue damage 
- Role in pathogenesis of many diseases 
[17] 
GOLDNANOPARTICLES /GOLD COLLOID SOLUTION 
Nanotechnology is used for controlling multiple medical processes with effective 
influence on medicine .Nanotechnology is the engineering of functional systems at the 
molecular scale which involves several interdisciplinary fields, such as medicine, 
electronics, and biomaterials. Nanoparticles offer alternative option in cancer therapy 
both as drug delivery carriers and as direct therapeutic agents for cancer cell inactivation. 
Goldnanoparticles /Colloidal Gold nanoparticle suspensions have been used in 
medicine from the ancient era. The size of particle varies from 10 to 100nm. Colloidal 
gold nanoparticles emit either an intense red colour (for particles 25nm) or green (for 
particles 50nm). Particles less or more than that emit different colours. Gold nano 
particles occur as clusters of gold atoms up to 100nm in diameter. They have unique 
optical, electronic, and molecular-recognition properties they are the subject of 
substantial research, with applications in a wide variety of areas in the field of medicine. 
Colloidal gold suspensions are widely used in imaging techniques such as detection of 
cancer etc. due to their fluorescent properties. Colloidal gold nanoparticles (AuNPs) are 
utilized in many modern technological and medical applications because of its unique 
characteristic in interaction with visible light. Their optical and electronics characteristics 
gave the chance to be applied in electronic uses, for example, as sensory probes,  
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Bioimaging, agents for medical therapy, drug delivery, medical applications and 
electronic instrumentalists. They are used in therapeutic agent carriage due to its large 
surface area/volume ratio, allowing their surface to be coated with numerous types of 
molecules including therapeutics and targeting agents. 
[18]
 
                      Among the currently investigated metal-based chemotherapeutic agents, 
gold nanoparticles hold a promising future as these compound exhibit different oxidation 
states and lower toxicity compared to other metal-based drugs. Generally, Gold 
nanoparticles with oxidation states II and III have potential applications in the field of 
medicine, particularly as chemotherapeutic agents for various cancers.   
CHARACTERISTICS OF GOLD NANOPARTICLES 
 Gold nanoparticles are chemically inert  
 These have greater biological compatibility  
 Optical properties like plasmon resonance are fluorescence and 
chemiluminescence having better exhibited by gold nanoparticles  
 Gold nanoparticles provide microscopic probes for the study of the cancer cell  
 Gold nanoparticles accumulate in the cancerous cell and show the cytotoxic 
effect i.e. apoptosis or necrosis of the specific cell and cell specific receptor  
 These have high stability due to the gold-sulphur bonds 
BIOLOGICAL PROPERTIES OF GOLD NANOPARTICLE 
 Most of the biological applications of gold nanoparticles use it as a passive agent, 
either as a probe for electron microscopy or as a vehicle to deliver biomolecules 
into cells 
 gold nanoparticles can be used as active agents to interfere directly with the 
cellular processes and possess anti-angiogenic and anti-tumor properties 
 Gold nanoparticles can also be fabricated as a multifunctional nanoplatform for 
various biomedical applications such as detection and diagnosis 
 Utilized the multifunctional platform of AuNPs by conjugating an antibody to 
bind to epidermal growth factor receptors (EGFR).
[19]
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GOLD NANOPARTICLES AGAINST CANCER 
Metal complexes have dominated the modern-day use of drugs in cancer. Gold 
nanoparticles have been used widely in the treatment of various malignant tumors as 
chemotherapeutic agents. [20] Gold compounds are potential antitumor agents their use 
has been limited due to their mandatory side effects in the modern-day treatment of 
cancer. Development of resistance to drugs has also minimized the use of gold 
compounds in the current treatment of cancer. These unresolved disadvantages potentiate 
the research on cancer in the quest to find alternatives for the treatment of cancer .Gold 
complexes in cancer were highlighted in the early 1970s and 1980s. Gold phosphine 
complexes were the first to investigate for their antitumor activity in gold complexes. 
Auranofin a gold I phosphine complex showed excellent antitumor property in mice 
bearing in P388 leukemia. [21] 
GOLD NANOPARTICLES AGAINST ANTI INFLAMMATORY 
Gold nanoparticles increase cutaneous wound healing in mouse through its anti-
inflammatory and antioxidative effects. AuNPs have anti-inflammatory properties 
through their capability to hinder expression of NF-kappa B and consequent 
inflammatory reactions.  Many researchers have studied the anti-inflammatory effect of 
various nanoparticles and the releasing of pro-inflammatory cytokines, such as tumor 
necrosis factor alpha (TNF-α) and interleukin (IL)-6 have been studied previously. The 
cytotoxic effects of gold nanoparticles were evaluated in macrophages and the 
expression of the inflammatory cytokines IL-6, IL-10 and TNF-α were quantified. It was 
found that NPs are cytotoxic to macrophages and are able to elicit an inflammatory 
response. [22] Gold or silver nanoparticles conjugated with heparin exhibited anti-
inflammatory properties without any significant effect on systemic hemostasis Chen et 
al. reported a reduction in TNF and IL-6 mRNA levels when 21-nm gold nanoparticles 
were injected into mice, a result attributed to fat loss and inhibition of inflammatory 
effects. Administration of nanoparticles of MnO2 caused accumulation of Mn in brain, 
spinal cord and muscle tissues of rats, leading to an impact on pain sensation. Finally, 
nanoparticles have also presented antitumor properties, which is quite interesting from 
the viewpoint of formulating new drugs against cancer. 
[23]
 
INTRODUCTION 
 
Department of Pharmacology  Page 13 
 
 
 
Figure: 2. Summary of mechanisms for the involvement of inflammation in cancer 
development. Tumor promotion indicates the process during which initiated cells 
develop into benign lesions. Tumor progression defines the process during which benign 
tumors progress to malignant carcinomas. 
[24]
 
 
APPLICATIONS OF GOLD NANOPARTICLES 
A list of some of the applications of nano materials to biology or medicine is given 
below: 
 Fluorescent biological labels  
 Drug and gene delivery  
 Bio detection of pathogens  
 Detection of proteins  
 Probing of DNA structure  
 Tissue engineering  
 Tumour destruction via heating (hyperthermia)  
 Separation and purification of biological molecules and cells  
 MRI contrast enhancement  
 Phagokinetic studies [25] 
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2. REVIEW OF LITERATURE 
Nikolaos m. dimitriou et al., (2017) studied gold nanoparticles, radiations and the 
immune system: Current insights into the physical mechanisms and the biological 
interactions of this new alliance towards cancer therapy. Considering both cancer's 
serious impact on public health and the side effects of cancer treatments, strategies 
towards targeted cancer therapy have lately gained considerable interest. Employment of 
gold nanoparticles (GNPs), in combination with ionizing and non-ionizing radiations, 
has been shown to improve the effect of radiation treatment significantly. GNPs, as high-
Z particles, possess the ability to absorb ionizing radiation and enhance the deposited 
dose within the targeted tumors. 
[26] 
 
Sejal Patel et al., (2016) revealed that annonaceous acetogenins are the major 
constituents of A. muricata. More than 100 annonaceous acetogenins have been isolated 
from leaves, barks, seeds, roots and fruits of A. muricata. It has wide potent 
anticancerous agents and it plays a key role towards many varieties of cancer, 
Acetogenins are potent inhibitors of NADH oxidase of the plasma membranes of cancer 
cells. These activities include anticancer, anticonvulsant, anti-arthritic, antiparasitic, 
antimalarial, hepatoprotective and antidiabetic, analgesic, hypotensive, antiinflammatory, 
and immune enhancing effects. The most promising activities are found to be its 
anticancer. 
[27] 
 
Ana V. Coria-Te et al., (2016) reviewed and focused on the phytochemicals contents, 
bioactivity, biological actions and toxicological aspects of extracts and isolated 
compounds, as well as medicinal uses of A. muricata had been identified in tropical 
regions to treat diverse ailments such as fever, pain, respiratory and skin illness, internal 
and external parasites, bacterial infections, hypertension, inflammation, diabetes and 
cancer. More than 200 chemical compounds has been identified and isolated from this 
plant the most important being alkaloids, phenols and acetogenins. Using in vitro studies, 
extracts and phytochemicals of A. muricata have been showed as an antimicrobial, anti- 
inflammatory, anti-protozoan, antioxidant, insecticide, larvicide, and cytotoxic to tumor 
cells. In vivo studies of the crude extracts and isolated compounds of A. muricata has  
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Showed to possess anxiolytic, anti-stress, anti-inflammatory, contraceptive, antitumoral, 
antiulceric, wound healing, hepato-protective, anti-icteric and hypoglycemic activities.
[28]
 
 
Liu N et al., (2016) showed the extracts of Annona muricata used to cause apoptosis of 
various cancer cells in vitro, and inhibit tumor growth in vivo in animal models. 
Investigated the molecular mechanisms underlying liver cancer cell apoptosis triggered 
by the ethanol extract of leaves of Annona muricata .Liver cancer HepG2 cells were used 
as experimental model. MTT assay has employed and evaluated the cell viability. 
Showed that the extract was able to reduce viability and trigger apoptosis of the cancer 
cells. Proteomic analysis identified 14 proteins associated with the extract-elicited 
apoptosis, which included the increased expression levels of HSP70, GRP94 and DPI-
related protein 5. Western blot analysis confirmed that the extract did up-regulated the 
protein levels of HSP70 and GRP94. Results from bio informatic annotation pulled out 
two molecular pathways for the extract notably, included endoplasmic reticulum (ER) 
stress. Results indicated that the ethanol extract of leaves of Annona muricata. Apoptosis 
of liver cancer cells through ER stress pathway, which supports the ethnomedicinal use 
of this herb as an alternative or complementary therapy for cancer. 
[29] 
 
L.A. Dykman et al., (2016) studied Biomedical Applications of Multifunctional Gold-
Based Nanocomposites andActive application of gold nanoparticles for various 
diagnostic and therapeutic purposes started in recent decades due to the emergence of 
new data on their unique optical and physicochemical properties. In addition to colloidal 
gold conjugates,growth in the number of publications devoted to the synthesis and 
application of multifunctional nanocomposites has occurred in recent years. This review 
considers the application in biomedicine of multifunctional nanoparticles that can be 
produced in three different ways. The first method involves design of composite 
nanostructures with various components intended for either diagnostic or therapeutic 
functions. 
[30] 
 
Khwaja Salahuddin Siddiqi et al., (2016) Observed Recent advances in plant-mediated 
engineered gold nanoparticles and their application in biological system. For 
biosynthesis of gold nanoparticles different parts of a plant are used as they contain  
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Metabolites such as alkaloids, flavonoids, phenols, terpenoids, alcohols, sugars and 
proteins which act as reducing agents to produce nanoparticles. They also act as capping 
agent and stabilizer for them. They are used in medicine, agriculture and many other 
technologies. The attention is therefore focussed on all plant species which have either 
aroma or colour in their leaves, flowers or roots for the synthesis of nanoparticles 
because they all contain such chemicals which reduce the metal ions to metal 
nanoparticles. 
[31] 
 
Ferdousi Akter et al., (2016) evaluated pharmacological and toxicological studies of an 
ayurvedic medicine Rasaraj  Ras on biological system of the male Sprague-Dawley rats. 
In this study, the pharmacological and toxicological effects alongwith possible side 
effects of the classical ayurvedic formulation Rasaraj Ras (RR) which is used as a 
traditional medicine in the treatment of hemiplegia in the rural population were 
evaluated. All throughout the experimental period the RR treated animals were always 
maintaining negligible changes in body weight, but all throughout the experimental 
period no statistically significant increase or decrease was noted. There is a statistically 
significant decrease in the relative percent weight of the male rat heart. There is a 
statistically highly significant decrease in the absolute weight of the male rat liver. 
[32] 
 
Micah D. K. Glasgow et al., (2016) studied Recent Developments in Active Tumor 
Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer 
Treatment and Imaging. Nanotechnology and combination therapy are two major fields 
that show great promise in the treatment of cancer. The delivery of drugs via 
nanoparticles helps to improve drug’s therapeutic effectiveness while reducing adverse 
side effects associated with high dosage by improving their pharmacokinetics. Taking 
advantage of molecular markers over-expressing on tumor tissues compared to normal 
cells, an “active” molecular marker targeted approach would be beneficial for cancer 
therapy. These actively targeted nanoparticles would increase drug concentration at the 
tumor site, improving efficacy while further reducing chemo-resistance. 
[33]
 
 
Rosa Raybaudi-Massilia et al., (2015) evaluated the cytotoxic activity of aqueous and 
alcoholic extracts from Annona muricata L(soursop) seed and pulp on human tumor cell  
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lines of breast, prostate and cervix; as well as the antioxidant and antimicrobial 
properties of those extracts. The methanolic extract of soursop seed was obtained by two 
methods: Soxhlet apparatus and maceration. Human tumor cell lines from breast (MCF-7 
and SKBr3), prostate (PC3) and cervix (HeLa), and fibroblasts (as control) were 
determined by the cytotoxic activity by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide) assay.Antioxidant and antimicrobial activity were 
determined by the DPPH (1,1-diphenyl-2-picrylhydrazyl) and disc diffusion method 
respectively. This research suggested that consumption of soursop fruit will be a good 
alternative to prevent illness such as cancer of prostate and cervix. 
[34] 
 
Shamshad Alam et al., (2015) suggested that the plant-based dietary supplements can 
reduce the risk of liver cancer. Nexrutine(NX), an herbal extract from 
Phellodendronamurense, has been shown the anti-inflammatory, anti-microbial and anti-
tumor activities. The study has shown an anti-tumor potential of NX against Solt-Farber 
model with elimination of PH, rat liver tumor induced by diethylnitrosoamine (DEN) as 
carcinogen and 2-acetylaminofluorene (2-AAF) as co-carcinogen. The elucidation of 
mechanistic path-ways has explored in human liver cancer cells. Dietary intake has 
significantly decreased the cell proliferation and inflammation, as well as increased 
apoptosis in the liver sections of DEN/2-AAF-treated rats. Moreover, NX significantly 
decreased the viability of liver cancer cells and modulated the levels of Bax and Bcl-2 
proteins levels. NX treatment resulted there is an increase in cytochrome-c release and 
cleavage of caspases 3 and 9. In addition, NX decreased the expression of CDK2, CDK4 
and associated cyclins E1 and D1, while up-regulated the expression of p21, p27 and p53 
expression. NX also enhanced phos-phorylation of the mitogen-activated protein kinases 
(MAPKs) ERK1/2, p38 and JNK1/2.Collectively, that these study suggested that NX- 
mediated protection against DEN/2-AAF-induced liver tumorogenesis involves decrease 
in cell proliferation and enhancement in apoptotic cell death of liver cancer cells. 
[35] 
 
Olaoluwa Oyedeji et al., (2015) showed the biocidal activities of A. muricata leaf and 
the extracts were evaluated against 10 clinical strains of bacteria and 6 fungal strains. 
The ethyl acetate and n-butanol fractions of the leaf extract exhibited the highest 
antibacterial effects and indicated that greater quantities of the inherent bioactive agents  
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are extracted by these solvents. The extract showes broad spectrum antimicrobial effects 
which compared favorably with those of reference drugs – streptomycin and 
amphotericin B. Moreover, the n-butanol could be a better solvent for the extraction of 
the antifungal compounds from A. muricata leaf.  This study has demonstrated 
appreciable biocidal activities of A. muricata leaf extracts which justify the 
ethnomedicinal use of the plant. 
[36] 
 
Jyothy k bhaskaran et al., (2015) evaluate the effect of swarna bhasma on memory and 
learning in swiss albino mice. The study was conducted to evaluate the effect of swarna 
bhasma on memory and learning against hyoscine/ scopolamine induced amnesia in 
albino mice. Administration of gold in children is a popular practice in ayurveda. it is 
stated that pure gold if administered along with honey and ghee for a period of 6 months 
will enable the infant to remember things which are just heard. The trial drug showed 
significant decrease in transfer latency (p<0.05) both on 2nd and 3rd day of the study 
when compared with initial values and the control group. Swarna bhasma exhibited 
significant therapeutic effects on memory and learning in albino mice. 
[37] 
 
Neha Mohan. P. V et al., (2015) evaluated anti-inflammatory activity in ethanolic 
extract of Coriandrum sativum L. using carrageenan induced paw oedema in albino rats. 
The present study investigates the anti-inflammatory activity in ethanolic extract of 
Coriandrum sativum. L using carrageenan induced paw edema in albino rats.The 
medicinal values of the Coriandrum sativum. L has been mentioned ancient literature as 
useful in disorders of inflammation.Dried leaves of Coriandrum sativum,powdered and 
extracted with ethanol using shaker. The anti-inflammatory was done by carrageenan 
induced hind paw edema method using plethysmometer. Indomethacin used as a 
standard drug. 
[38]
 
 
Balan Rajan et al., (2015) observed Carvacrol attenuates N-nitrosodiethylamine induced 
liver injury in experimental Wistar rats. Carvacrol is a main constituent in the essential 
oils of countless aromatic plants including Origanum Vulgare and Thymus vulgari, 
which has been assessed for substantial pharmacological properties. In recent years, 
notable research has been embarked on to establish the biological actions of  
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Carvacrol for its promising use in clinical applications. The present study is an attempt to 
reveal the protective role of Carvacrol against N-Nitrosodiethylamine (DEN) induced 
hepatic injury in male wistar albino rats. DEN is an egregious toxin, present in numerous 
environmental factors, which enhances chemical driven liver damage by inducing 
oxidative stress and cellular injury. 
[39] 
 
Sherien k hassan et al., (2014) therapeutic and chemopreventive effects of nano 
curcumin against diethylnitrosamine induced hepatocellular carcinoma in rats. The 
present study is designed to investigate the preventive and therapeutic effects of nano 
curcumin (Nano Cur) against diethylnitrosamine (DEN) induced hepatocellular 
carcinoma (HCC) in rats. Administration of DEN to rats in group II significantly 
increased relative liver weight, serum liver function enzymes, serum sialic acid, vascular 
endothelial growth factor and hepatic thiobarbituric acid reactive substances this was 
accompanied by significant decrease in serum albumin and tissue antioxidants (GPx, 
GST, SOD, CAT and GSH). 
[40] 
 
B. Arirudran et al., (2014) alteration in levels of minerals in den induced hepatocellular 
carcinoma in wistar albino rats. The present attempt has been made to evaluate, and 
examine the levels of minerals in serum and liver in DEN induced hepatocellular 
carcinoma in wistar albino rats for possible chemopreventive effect. In hepatocellular 
carcinogenesis complications such as hepatic fibrosis and cirrhosis may lead to several 
abnormalities in mineral metabolism, hence attempt is made to evaluate on the level of 
minerals. Hepatic cancer was induced by single dose of intraperitoneal injections of DEN 
(200mg/kg body weight) followed by phenobarbital of 0.05% mixed with drinking water 
for 20 weeks. Concentration of calcium, magnesium, sodium and potassium were 
assessed in the serum and liver at the end of experimental period. 
[41]
 
 
Jihyoun Lee et al., (2014) Evaluated Gold nanoparticles in breast cancer treatment: 
Promise and potential pitfalls. Despite remarkable achievements in the treatment of 
breast cancer, some obstacles still remain. Gold nanoparticles may prove valuable in 
addressing these problems owing to their unique characteristics, including their enhanced 
permeability and retention in tumor tissue, their light absorbance and surface plasmon  
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resonance in near-infrared light, their interaction with radiation to generate secondary 
electrons, and their ability to be conjugated with drugs or other agents. 
[42] 
 
Rajesh kumar soni et al., (2014) Observed anti-inflammatory activity of kirganelia 
reticulata (poir). baill. root by carrageenan-induced rat paw oedema model.  to evaluate 
anti-inflammatory activity of ethanolic roots extract of kirganelia reticulata (poir). baill. 
by carrageenan- induced rat paw oedema . ethanolic roots extract of k. reticulata was 
investigated for anti-inflammatory activity by carrageenan induced right hind rat paw 
oedema in wistar rats at the dose of 200 and 300mg/kg, p. o. (per orally). The ethanolic 
extract of k. reticulata root shows significant anti-inflammatory activity (p<0.05 and 
p<0.01) at the dose of 300mg/kg, p.o. p < 0.001 .when compared to control.  The results 
obtained demonstrated that ethanolic roots extract of k. reticulata (poir) baill. has 
potential health benefits as it showed dose dependant anti-inflammatory activity. 
[43] 
 
Khetbadei Lysinia Hynniewta Hadem et al., (2014) Observed Inhibitory potential of 
methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular 
carcinoma induced by diethylnitrosamine in BALB/c mice.This study was to evaluate the 
anti-carcinogenic properties of the crude methanolic extracts of roots of AT and 
rhizomes of CC in BALB/c mice.Exposed to a hepatocarcinogen, diethylnitrosamine 
(DEN). To evaluate the effects of these two HPE either alone or following DEN 
exposure, serum transaminases (aspartate aminotransferase [AST], alanine 
aminotransferase [ALT]), alkaline phosphatase (ALP), and cancer marker enzyme 
acetylcholine esterase (AChE) were assayed in mice. 
[44]
 
 
Arun raj.R et al., (2014) evaluated the methanolic extract of Gordonia obtusa 
(Theaceae) for its effects on growth in MCF-7 breast cancer cell lines using MTT assay. 
These cell lines studied the extract decreased cell viability, inhibited cell proliferation, 
and induced cell death in a dose dependent manner. The present study demonstrated that 
methanolic leaf extract of Annona muricata showed more anti-cancer activity compared 
to its bark extract. The methanolic leaf and bark extracts of Annona muricata was tested 
for its antibacterial effect successfully showed zone of inhibition against the tested 
microorganism. The maximum zone of inhibition was shown by the methanolic leaf  
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extract of Annona muricata against Escherichia coli. So it could be a reliable source of 
potent pharmacophore for treatment of disease like cancer. 
[45] 
 
Mitsuru Futakuchi et al., (2013) observed that N-nitrosomorpholine (NMOR) given 
after a multi-carcinogenic treatment induced liver carcinomas with 56% lung metastasis. 
An additional treatment with diethylnitrosamine (DEN) with NMOR further enhanced 
the incidence of hepatocellular carcinoma (HCC) with lung metastasis. It is further 
revised the duration of NMOR treatment to establish an animal model with a simple 
experimental protocol and mechanisms of HCC metastasis and development of anti-
metastatic therapeutics. Observed that the DEN exposure followed by 16-week treatment 
with NMOR to be a most efficient protocol for the induction of hepatocellular 
metastasizing to the lung. 
[46] 
 
Attalla f. el-kott et al., (2013) studied the histopathological, immunohisto chemical and 
ultrastructural alterations following administration of nigella sativa in rats hepatocellular 
carcinoma. Hepatocellular carcinoma (HCC) is the 3rd greatest cause of carcinoma-
related deaths. In the present study, the Nigella sativa was used as a pharmaceutical 
agent in the hepatocarcinogenesis of rats which induced by Diethylnitrosamine (DEN). 
Four groups of animals were used and fed ad libitum. The 1st group was a control; the 
2nd was fed ad libitum and given 0.2 g/rat/day orally in a watery suspension till the time 
of sacrifice. The 3rd group was intraperitoneally injected with a single dose of DEN 150 
mg k-1 b.wt. The 4th group was intraperitoneally injected with DEN and after one week, 
the each rat was given Nigella sativa as in group 2 at dose 0.2 g/rat/day. 
[47]
 
 
Sohail Akhter et al., (2012) evaluated Gold nanoparticles in theranostic oncology: 
current state-of-the-art and observed the recent progress in the field of gold 
nanomaterials in cancer therapy and diagnosis. Moreover, concern about the toxicity of 
gold nanomaterials is addressed. Gold nanoparticles (GNPs) have gained much attention 
as platform for drug delivery and diagnostic applications because of their unique surface 
characteristics, allowing easy functionalization with chemicals that alter their circulation 
behavior or redirect them to target cells. 
[48] 
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Magda Ismail Youssef et al., (2012) studied Expression of Ki 67 in hepatocellular 
carcinoma induced by diethylnitrosamine in mice and its correlation with 
histopathological alterations. Hepatocellular carcinoma (HCC) is one of the most 
common malignant tumors worldwide and the prognosis still remains dismal, so the 
present work was planned to assess the prognostic value of Ki67 in mice model of HCC 
induced by diethylnitrosamine (DEN), in addition to its correlation to the 
histopathological changes. histopathological study revealed spotty necrosis with enlarged 
nuclei and cholestasis 6 weeks after DEN injection. 
[49] 
 
Anil Kumar et al., (2012) observed the Gold nanoparticles functionalized with 
therapeutic and targeted peptides for cancer treatment. Functionalization of 
nanostructures such as gold nanoparticles (AuNPs) with different biological molecules 
has many applications in biomedical imaging, clinical diagnosis and therapy. 
Researchers mostly employed AuNPs larger than 10 nm for different biological and 
medicinal applications in previous studies. Herein, we synthesized a novel small (2 nm) 
AuNPs, which were functionalized with the therapeutic peptide, PMI (p12), and a 
targeted peptide, CRGDK for selective binding to neuropilin-1(Nrp-1) receptors which 
overexpressed on the cancer cells and regulated the process of membrane receptor 
mediated internalization. 
[50]
 
 
Srisesharam srigopalram et al., (2012) studied the effect of terminalia chebula retz on 
den induced hepatocellular carcinogenesis in experimental rats. hepatocellularcarcinoma 
(HCC), a highly aggressive form of solid tumor, has been increasing in south east asia. 
The lack of effective therapy necessitates the introduction of novel chemo preventive 
strategies to counter the mortality associated with the disease. Towards this goal, the 
present study evaluates the chemo preventive potential of t.chebula aqueous extract (tce) 
by estimating the levels of lipid peroxidation and assaying activities of various marker 
enzymes in diethylnitrosamine (den) induced liver cancer bearing rats. the daily oral 
treatment of tce (50 mg/kg bwt) to liver cancer bearing rats demonstrated a significant 
(p<0.05) decline in lipid peroxidation, pathophysiological marker enzyme (ast, alt, alp, 
ldh, γ-gt and 5’nt) levels and increase in enzymic antioxidants (sod, cat, gpx, gr and gst) 
status. 
[51] 
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Erik C Dreaden et al., (2012) Studied size matters: gold nanoparticles in targeted cancer 
drug delivery. Cancer is the current leading cause of death worldwide, responsible for 
approximately one quarter of all deaths in the USA and UK. Nanotechnologies provide 
tremendous opportunities for multimodal, site-specific drug delivery to these disease 
sites and Au nanoparticles further offer a particularly unique set of physical, chemical 
and photonic properties with which to do so. This review will highlight some recent 
advances, by our laboratory and others, in the use of Au nanoparticles for systemic drug 
delivery to these malignancies and will also provide insights into their rational design, 
synthesis, physiological properties and clinical/preclinical applications, as well as 
strategies and challenges toward the clinical implementation of these constructs moving 
forward. 
[52] 
 
K. Balamurugan et al., (2012) evaluation of Luteolin in the Prevention of N-
nitrosodiethylamine-induced Hepatocellular Carcinoma Using Animal Model System. 
Hepatocellular carcinoma (HCC) is one of the commonest tumors worldwide. The 
treatment of HCC is vital for disease diagnosis and prognosis, as the liver is the most 
important organ controlling metabolic functions. Now-adays, western folklore medicines 
are largely dependent on the phyto compounds which are highly effective in therapy and 
with low side effects. Luteolin is a flavonoid (3,4,5,7-Tetrahydro flavones) possess anti-
inflammatory, anticancer and anti-allergic property. 
[53]
 
 
Sasika d. bhalke et al., (2012) studied anti- inflammatory and anti nocicep tive activity 
of pterospermum acerifolium leaves.  pterospermum acerifolium  willd (family: 
sterculiaceae) has long been used traditionally for the treatment of painful inflammatory 
conditions in the indian folk medicine. in the present study we have evaluated 
antinociceptive effects and anti-inflammatory effects of unsaponified petroleum ether 
extract of pterospermum acerifolium leaves (uspel, 100 and 200 mg/kg orally) and 
isolated β-sitosterol (10 and 20 mg/kg) from the leaves. uspel and β-sitosterol are 
evaluated for its anti-inflammatory activity in carrageenan-induced paw edema model in 
rats and analgesic activity in acetic acid-induced writhing, hot plate and formalin induced 
paw licking models in mice. 
[54] 
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Zhao-Zhin Joanna LIM et al., (2011) studied the Gold nanoparticles in cancer therapy. 
The rapid advancement of nanotechnology in recent years has fuelled a burgeoning 
interest in the field of nanoparticle research, in particular, its application in the medical 
arena. A constantly expanding knowledge based on a better understanding of the 
properties of gold nanoparticles (AuNPs) coupled with relentless experimentation means 
that the frontiers of nanotechnology are constantly being challenged. At present, there 
seems to be heightened interest in the application of AuNPs to the management of 
cancer, encompassing diagnosis, monitoring and treatment of the disease. 
[55] 
 
Naina Mohamed Pakkir Maideen et al., (2011) evaluated the chemopreventive effect 
of methanol extract of Phyllanthus polyphyllus (MPP) against N-nitrosodiethylamine 
(DEN) induced liver Phenobarbital promoted tumor. These agents  significantly reduces 
tumor incidence, delay tumor onset and also have minimal long-term toxicity, The 
present study was undertaken to establish the cancer chemopreventive efficacy of MPP 
against DEN induced malignancy of liver.The extract phyllanthus polyphyllus shows 
result for hepatocarcinoma. 
[56] 
 
C. Lasagna-Reeves et al., (2010) performed the Bioaccumulation and toxicity of gold 
nanoparticles after repeated administration in mice. Gold nanoparticles (GNPs) offer a 
great promise in biomedicine. Currently, there is no data available regarding the 
accumulation of nanoparticles in vivo after repeated administration. The purpose of the 
present study was to evaluate the bioaccumulation and toxic effects of different doses 
(40, 200, and 400 μg/kg/day) of 12.5 nm GNPs upon intraperitoneal administration in 
mice every day for 8 days. The gold levels in blood did not increase with the dose 
administered, whereas in all the organs examined there was a proportional increase on 
gold, indicating efficient tissue uptake. 
[57] 
 
Philippa Newell et al., (2008) carried out experimental models for hepatocellular 
carcinoma by using mouse (mus musculus) as experimental animal and it has considered 
the best model systems for cancer because of the availability of gene targeting methods. 
They have used some of the technical methods for evaluation such like: 1.xenograft: 
Orthotopic xenograft: model in which hepatoma 129 cells originating from C3H mice are  
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injected into fibrotic livers of mice pretreated with TAA and EtOH, 2.Transgenic 
method: inducible transgenic: Tet-inducible Met expression under albumin promoter: 
60% HCC at 12 months; tumors regressed when transgene (Tg) has been inactivated 
3.endogenous GEM: conditional gene targeting: Cre-mediated liver specific PTEN-/- 
knockout: 66% HCC at 8 months. They had described both traditional models of 
carcinogenesis had an expression of oncogenes and tumor suppressor genes in 
genetically altered to produce HCC, and in other models tumor formation occurs 
dependent on inflammation, hence these (mus musculus) mice may show good response 
for animal while hepatocellular carcinoma screening is done. 
[58]
 
 
Nermin A. H. Sadik et al., (2008) designed to study the efficacy of dietary 
supplementation with blueberries (BB) on diethylnitrosamine (DEN)-initiated 
hepatocarcinogenesis in male wistar rats. The results showed that BB caused significant 
decrease in the elevated serum levels of alpha-fetoprotein (AFP), homocysteine (Hcy) 
along with levels of glutathione (GSH), deoxyribonucleic acid (DNA), ribonucleic acid 
(RNA)and activity of Glutathione reductase (GR) in liver. Normalization of elevated 2-
macroglobulin (2M) and total antioxidant capacity (TAC) levels in serum, hepatic 
glutathione-S-transferase (GST), glutathione peroxidase (GPx) activities and liver weight 
was achieved whereas body weight was significantly decreased. Moreover, no significant 
change was observed in elevated relative liver weight, hepatic glucose-6-P-
dehydrogenase (G6PD), lactate dehydrogenase (LDH) along with serum amino 
transferases, alkaline phosphatase (ALP) and glutamyltransferase (GT) activities. 
Significant increase in reduced hepatic activity of xanthine oxidase (XO) was achieved 
and histopathological damage was minimized in BB-treated group. It is suggested that 
BB suppress DEN- induced hepatocarcinogenesis and could be developed as a promising 
chemopreventive natural supplement for liver cancer. 
[59]
 
 
Sonia bajaj et al., (2000) studied anti-cataleptic, anti-anxiety and anti-depressant 
activity of gold preparations used in indian systems of medicine. Traditional gold 
preparations used in Ayurveda and Unani-Tibb exhibited anxiolytic, antidepressant and 
anti-cataleptic actions with wide margin of safety. Anxiety, depression and mental health 
problems in general and senile neurological disorders in particular are widely prevalent  
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in modern fast-paced life with a multitude of stressful conditions While gold is used only 
for the treatment of rheumatoid arthritis in modern medicine 7-9 it is attributed with 
varied medicinal properties in Ayurveda and Unani-Tibb including nervine tonic effects 
and utility in neuropsychiatric. 
[60] 
 
Ranjan basak et al ., (2000) evaluated inhibition of Diethylnitrosamine  induced rat 
liver chromosomal and the DNA-strand breaks by synergistic supplementation of 
vanadium and 1K,25-dihydroxyvitamin D3.These drug has inhibited growth and induced 
differentiation of a variety of cell types. Synergistic of both V and 1, 25(OH)2D3  DEN 
injection has found to offer significant protection against generation of single-strand 
breaks. The study has result of elevation of the mitotic rate in the Liver. Therefore, it 
seems possible that the elevation of the mitotic rate during DEN treatment favored 
production and increase in the number of cells with abnormal chromosomes, and the 
drug (vanadium and 1K, 25-dihydroxyvitamin D3) shows an anti hepatocarcinogenesis 
activity. 
[61] 
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3. AIM & OBJECTIVE 
 
AIM 
The aim of the present study was to evaluate the pharmacological action of Gold 
nanoparticles. 
 
 
OBJECTIVE 
The objectives of the present study include: 
 Evaluation of  in vitro anti-cancer activity  
 Evaluation of  in vivo anti-inflammatory activity 
 Evaluation of in vivo anti-cancer activity  
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4. PLAN OF WORK 
 
 Review of literature 
 Qualitative analysis (Particle size, Surface property, Elemental composition) 
 Acute toxicity studies 
 Evaluation of anti-cancer study 
      1. DEN induced liver cancer (in vivo) 
       2. MTT assay (in vitro) 
  Evaluation of anti-inflammatory activity 
      1. Carrageenan induced paw oedema 
      2. Histamine induced paw oedema 
      3. Serotonin induced paw oedema 
 Parameters to be evaluated 
  Estimation of serum biochemical parameters 
1. SGOT 
2. SGPT 
3. Alkaline phosphate (ALP) 
4. Total protein 
             Estimation of Haematological parameters 
1. Red blood cells (RBC) 
2. White blood cells (WBC) 
Physical parameters  
1. Body weight 
2. Liver weight 
 Histopathological studies 
 Statistical analysis 
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5. MATERIALS AND METHODS 
5.1. Collection of the Formulation 
Thanga parpam was procured from Jaya indian medicine pharmaceutical PVT.LTD 
(Chennai) [62] 
5.1.1. Uses  
 Neuromuscular disorders 
 Respiratory disorder 
  Tremors(shake) 
 Supportive therapy in cancer 
 Arthritis 
 Low sperm count  
5.2. QUALITATIVE ANALYSIS (PARTICLE SIZE, SURFACE   PROPERTY, 
ELEMENTAL COMPOSITION) 
5.2.1. Synthesis and Characterization. 
Gold colloids were synthesized by reduction of chloroauric acid with sodium citrate 
using the Turkevich method. 
[63]
 
   The elemental composition of gold colloids was measured by ICP-MS 
(inductively Coupled Plasma Mass Spectroscopy) 7700x Agilent and Energy Dispersive 
Spectroscopy (EDS attached to SEM Hitachi S 3400N. The gold nanoparticle (Jaya) was 
suspended in DI water and deposited on pre-cleaned glass slides for SEM measurements. 
Dynamic Light Scattering (DLS) measurements were done by using a Nicomb 380 
instrument. Elemental composition was measured by EDS-SEM and ICP-MS after 
digestion with aqua regia. 
5.2.2. Turkevich method 
 The method pioneered by J. Turkevich et al. in 1951 and refined by G. Frens in 
the 1970s, is the simplest one available. In general, it is used to produce 
modestly monodisperse spherical gold nanoparticles suspended in water of  
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around 10–20 nm in diameter. Larger particles can be produced, but this comes at 
the cost of monodispersity and shape. It involves the reaction of small amounts of 
hot chloroauric acid with small amounts of sodium citrate solution. The colloidal 
gold will form because the citrate ions act as both a reducing agent and a capping 
agent.  
 Recently, the evolution of the spherical gold nanoparticles in the Turkevich 
reaction has been elucidated. It is interesting to note that extensive networks of 
gold nanowires are formed as a transient intermediate. These gold nanowires are 
responsible for the dark appearance of the reaction solution before it turns ruby-
red.  
 To produce larger particles, less sodium citrate should be added (possibly down 
to 0.05%, after which there simply would not be enough to reduce all the gold). 
The reduction in the amount of sodium citrate will reduce the amount of the 
citrate ions available for stabilizing the particles, and this will cause the small 
particles to aggregate into bigger ones (until the total surface area of all particles 
becomes small enough to be covered by the existing citrate ions). 
5.2.3. Dynamic light scattering (DLS) 
 Dynamic light scattering (DLS) is a technique in physics that can be used to 
determine the size distribution profile of small particles in suspension or 
polymers in solution. 
 In the scope of DLS, temporal fluctuations are usually analyzed by means of the 
intensity or photon auto-correlation function (also known as photon correlation 
spectroscopy or quasi-elastic light scattering). 
 In the time domain analysis, the autocorrelation function (ACF) usually decays 
starting from zero delay time, and faster dynamics due to smaller particles lead to 
faster decorrelation of scattered intensity trace. It has been shown that the 
intensity ACF is the Fourier transformation of the power Spectrum, and therefore 
the DLS measurements can be equally well performed in the spectral domain.  
 DLS can also be used to probe the behavior of complex fluids such as 
concentrated polymer solutions. 
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 DLS is used to characterize size of various particles including proteins, polymers, 
micelles, carbohydrates, and nanoparticles. If the system is not dispersing in size, 
the mean effective diameter of the particles can be determined.  
 Dynamic light scattering provides insight into the dynamic properties of soft 
materials by measuring single scattering events, meaning that each detected 
photon has been scattered by the sample exactly once.  
 
5.2.4. Field Emission Scanning Electron Microscopy (FESEM) 
To study the surface structure of the Gold nanoparticles and Gold colloid solution 
FESEM analysis was carried out on FEI Nova NanoSEM 450. Resolution: 1.0 nm at 
15kV, 1.4 nm at 1kV and 1.8 nm at 3kV and 30Pa. Software used was xT microscope 
control.  
5.2.5. X-Ray Diffraction (XRD)  
 XRD measurements were carried out in symmetric reflection mode with a 
custom-built diffract meter equipped with pyrolytic graphite monochromator and 
analyzer crystals. 
 The elemental composition of the Gold nanoparticle was confirmed used XRD 
analysis. 
 The XRD pattern of Gold nanoparticle and Gold colloid solution sample reflects 
gold metal as the major phase along with certain impurities 
 Cu K-alpha radiation = 0.15418 nm was used for the measurements 
5.2.6. Energy Dispersive X-ray Spectrometry (EDS) 
Elemental composition of the Gold nanoparticle and Gold collid solutions are determined 
by EDS analysis. It was carried out on Bruker X Flash 6I30. Resolution: 123eVat Mn k-
alpha and 45eV at C K-alpha and element detection range from 4 Be to 95 Am. Software 
used was Espirit 1.9. 
[63] 
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5.3. IN VITRO ANTICANCER ACTIVITY 
5.3.1. MTT assay  
 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT) is a yellow 
water soluble tetrazolium salt. A mitochondrial enzyme in living cells, succinate-
dehydrogenase, cleaves the tetrazolium ring, converting the MTT to an insoluble purple  
formazan. Therefore, the amount of formazan produced is directly proportional to the 
number of viable cells. 
 After 48 h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered 
saline (PBS) was added to each well and incubated at 37
0
C for 4h. The medium with 
MTT was then discarded and the formed formazan crystals were solubilized in 100µl of 
DMSO and then measured the absorbance at 570 nm using micro plate reader. The 
percentage cell viability was then calculated with respect to control as follows 
% Cell viability = [A] Test / [A]control x 100 
5.3.2. Cell line 
The human breast adenocarcinoma cell line (MCF7) was obtained from National 
Centre for Cell Science (NCCS), Pune and grown in Eagles Minimum Essential Medium 
containing 10% fetal bovine serum (FBS). The cells were maintained at 370C, 5% CO2, 
95% air and 100% relative humidity. Maintenance cultures were passaged weekly, and 
the culture medium was changed twice a week. 
5.3.3. Cell treatment procedure 
 The monolayer cells were detached with trypsin-
ethylenediaminetetraacetic acid (EDTA) to make single cell suspensions and viable cells 
were counted by tryphan blue exclusion using a hemocytometer. Dilutions were made 
with medium containing 5% FBS to give final density of 1x105 cells/ml. One hundred 
microlitres per well of cell suspension were seeded into 96-well plates at plating density 
of 10,000 cells/well and incubated to allow for cell attachment at 370C, 5% CO2, 95% 
air and 100% relative humidity. After 24 h the cells were treated with serial 
concentrations of the test sample. The sample was initially dispersed in phosphate 
buffered saline and an aliquot of the sample solution was diluted to twice the desired  
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final maximum test concentration with serum free medium. Additional four serial 
dilutions were made to provide a total of five sample concentrations. Aliquots of 100 µl 
of these different sample dilutions were added to the appropriate wells already 
containing 100 µl of medium, resulting in the required final sample concentrations. 
Following sample addition, the plates were incubated for an additional 48 h at 370C, 5% 
CO2, 95% air and 100% relative humidity. The medium containing without samples 
were served as control and triplicate was maintained for all concentrations. 
[65, 66]
 
5.4. PHARMACOLOGICAL EVALUATION OF THE GOLD NANOPARTICLES 
 Animals and Diet 
Male Sprague Dawley rats weighing about 120-200gm were used for study. The 
animals were housed under controlled conditions of temperature (20-25
0
C) and 
photoperiod of 12-h light/dark cycle. 
All the rats were fed with pelletized commercial chow diet and fresh water ad 
libitum throughout the experimental period, and weight gain was measured in a weekly 
manner. 
All animal procedures were performed after obtaining approval from the animal 
ethical committee and accordance with the recommendations for the proper care and use 
of laboratory animals by CPCSEA. 
5.4.1. INVIVO ANTICANCER ACTIVITY 
5.4.1.1. DEN Induced Hepatocellular carcinoma 
Principle 
 Diethylnitrosoamine (DEN), also known as N-nitrosodiethylamine, is widely 
used as a carcinogen in experimental animal models. Upon administration of 
DEN to the animal, either orally or as intraperitoneal injection, tumors will be 
induced in organs like, liver, gastrointestinal tract, skin, respiratory tract and 
hematopoietic cells.   
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 DEN is not a direct carcinogen and hence it needs to be biotranformed by 
cytochrome P450 (CYP) enzymes present in the liver. This biotransformation in 
DNA-adducts formation carries through an alkylation mechanism.  
 CYP 2E1 has been considered to be important for DEN activation since 
CYP2E1-deficient animals show lower tumor incidence and multiplicity for 
DEN-induced hepatocarcinogenesis. This result firmly proposes that CYP2E1 
plays an indispensable role in the activation of DEN, although several other CYP 
enzymes are proposed to catalyze DEN bioactivation in vivo. 
[67]
 
Procedure 
5.4.1.2. Induction of Hepatocellular carcinoma  
Thirty six male Sprague Dawley rats were taken and divided in to six groups and each 
group contains six animals. All animals were fasted overnight. DEN 200 mg/kg was 
injected intraperitonealy by dissolving in normal saline for the induction of 
hepatocarcinoma for the groups 2 to 6 from the day 0. After 1 week, group 1 received 
only normal saline. Group 2 received only DEN (200 mg/kg), group 3 received 
standard drug (5-fluro uracil) intraperitoneally, group 4 and   5 received the treatment 
with the GNP (30 mg/kg and 60 mg/kg respectively) orally and group 6 received the 
treatment with the Gold colloidal solution intraperitoneally. After treatment for six 
weeks, the changes in body weight of the animals were observed. Then the animals 
were fasted overnight and the next day, the blood was collected from the animal 
through retro orbital puncture for the determination of hematological parameters and 
serum was separated for the estimation of biochemical parameters. The rats were 
sacrificed by cervical dislocation and the liver was isolated and sent to laboratory for 
histopathological study. 
[68]
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Table: 1 Pharmacological Model for DEN induced HCC 
Groups Sample Size Group Specification 
Group I 6 Normal (Normal saline) 
Group II 6 DEN Control 
Group III 6 
DEN + Standard  [5 Flurouracil (20mg/kg) body wt 
i.p)] 
Group IV 6 DEN+GNP(Low dose-30mg/kg) 
Group V 6 DEN + GNP (High dose-60mg/kg) 
Group VI 6 DEN+GCS (60µg/100g) 
 
5.4.2. ESTIMATION OF HAEMATOLOGICAL PARAMETERS 
Blood Collection 
After the end of the treatment period (90 days) of the animals were anaesthetized 
with ketamine (i.p) and its blood was collected by retro orbital puncture with addition of 
EDTA for the enumeration of blood cells i.e., RBC and WBC. The estimation of various 
biochemical parameters carried out by using blood sample without adding EDTA. 
Separation of Serum 
The serum was separated from the     blood     by centrifuging at 10,000 rpm for 
10 minutes. The separated serum was collected and used for the estimation of 
haematological parameters. For the estimation of the biochemical parameters such as 
Alkaline phosphatase (ALP), Serum glutamate oxalo acetate transaminase (SGOT), 
Serum glutamate pyruvate transaminase (SGPT), Serum creatinine and  total protein,  
Such as 
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5.4.3. Enumeration of red blood cells (RBC)  
Requirements 
 RBC diluting fluid (Hayem’s fluid) 
 Counting chamber (Neubauer’s chamber) 
 RBC pipette 
 Microscope with 45 X lens 
 Procedure 
 RBC pipette was filled with blood up to the mark 0.5. RBC diluting fluid 
(Hayem’s fluid) was filled up to the mark 101. The pipette was rolled between the palms 
to ensure thorough mixing of blood with diluting fluid and kept for some time. The 
counting chamber was placed and the RBC squares were focused under low power and 
after identification of the markings turn to high power. The first 3-4 drops of blood 
mixture was discarded and it was mixed once again. The counting chamber was charged 
with the mixed blood. After that mount the slide and allowed the fluid to settle down by 
using a 45 X lens. The RBC was counted in the corner and middle squares. The numbers 
of cells were expressed as 10
6
 cells/mm3. 
5.4.4. Enumeration of white blood cells (WBC) 
Requirements 
 WBC diluting fluid (Turk’s fluid) 
 Counting chamber (Neubauer’s chamber) 
 WBC pipette 
 Microscope with 45 X lens 
Procedure 
 WBC pipette was filled with blood up to the mark 0.5. RBC diluting fluid 
(Turk’s fluid) was filled up to the mark 11. The pipette was rolled between the palms to 
ensure thorough mixing of blood with diluting fluid and kept for some time. The 
counting chamber was placed and the WBC squares were focused under low power and  
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after identification of the markings turn to high power. The first 3-4 drops of blood 
mixture was discarded and it was mixed once again. The counting chamber was charged 
with the mixed blood. After that mount the slide and allowed the fluid to settle down by 
using a 45 X lens. The WBC was counted in the corner and middle squares. The number 
of cells was expressed as 10
3 
cells/mm3. 
[69]
 
5.4.5. Estimation of serum biochemical parameters 
5.4.5.1. Estimation of Alkaline phosphatase (ALP) 
Method 
Kinetic photometric test-according to IFCC (International Federation of Clinical 
Chemistry and Laboratory Medicine) 
Principle 
ALP hydrolysis P-Nitrophenyl phosphate to P-Nitrophenol and phosphate. 
Reaction 
P-Nitrophenylphosphate+H2O         P-Nitrophenol + phosphate 
Reagents 
                         Composition of ALP reagent 
 
 
 
 
 
 
 
 
Reagent Composition Quantity 
R1 
Diethanolamine 1.5 Mol/L 
Magnesiumchloride 0.6 m Mol/L 
R2 
p-Nitrophenyl 
PhosphateAnalogue 
0.070 m Mol/L 
Sodium Azide 10%  
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Procedure 
800 µL of Reagent 1 was taken in a 5ml test tube and to it 200 µL of Reagent 2 was 
added and mixed. To it 25 µL of serum sample was added and mixed well after the 
sample was allowed to run. 
[70]
 
5.4.5.2. Serum Glutamate Oxaloacetate Transaminase (SGOT) 
Principle 
SGOT 
L-aspartate+2-oxaloglutarate                               L-Glutamate + oxaloacetate 
LDH 
Oxaloacetate+ NADH+H
+                                                                 
D-Malate+NAD
+ 
This modified formula for the assay of AST/GOT, as recommended by the 
IFCC (International federation of clinical chemistry). The IFCC reference method 
includes pyridoxal phosphate (PP) function as coenzyme in AA transfer, therefore 
addition of PP results in increased enzyme activity. It avoids falsely low activity in 
samples containing insufficient endogenous PP, e.g. from patients with myocardial 
infarction, liver disease and intensive care patients. 
Method: Optimized UV test according to the IFCC (International Federation of 
Clinical Chemistry and laboratory medicine) 
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Composition of  SGOT reagent 
 
Procedure 
800 µL of Reagent 1 was taken in a 5 ml test tube and to it 200 µL of Reagent 2 was 
added and mixed. To it 100 µL of serum sample was added, mixed well and the sample 
was allowed to run. 
5.4.5.3. Serum Glutamate Pyruvate Transaminase (SGPT) 
Principle 
SGPT 
             L-alanine+2-oxoglutarate                             L -glutamate+pyruvate 
                              Pyruvate+NADH+H
+               
D-Lactate+NAD 
Addition of pyridoxal-5-phosphate (P-5-P) stabilizes the transaminases and avoids 
false low values in samples containing insufficient endogenous P-5-P, e.g. from 
patient with myocardial infarction, liver disease and intensive care patients. 
Method 
According to international federation of clinical chemistry and laboratory medicine 
(IFCC) 
Reagents Composition Quantity 
R1 
Tris pH-7.8 80 m Mol/L 
Preservatives  
Stabilizers  
R2 
L-Aspartate 240 mMol/L 
NADH 0.18 mMol/L 
Pyridoxal 5 Phosphate  
Lactate Dehydrogenase ≥900 U/L 
Malate Dehydrogenase ≥600 U/L 
Alpha Ketoglutarate 12 mmol/L 
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Reagents 
Composition of SGPT reagent 
Reagents Composition Quantity 
R1 
L- Alanine ≥200 U/L mMol 
LDH(lactate dehydrogenase) ≥1500 U/L 
2-Oxoglutarate 15 mMol/L 
R2 
NADH 1.05 mMol/L 
Pyridoxal-5-phosphate  
Alpha-ketoglutarate >35 mMol/L 
 
Procedure 
800µL of Reagent-1 was taken in a 5ml test tube and 200 µL of Reagent-2 was added 
and mixed. To it 100µL of serum sample was added and the sample was allowed to 
run.
[71] 
5.4.5.4. Estimation of Total Protein in Liver tissue 
Principle 
The method is based on the burette reaction, formation of a protein–copper complex and 
reduction of phosphour molybdenum tungstate reagent (Folin–Ciocalteu Phenol reagent) 
by tyrosine and tryptophan residues of protein to form a colored product. 
[72] 
Reagents  
Solution A: 1ml CuSO4 5.H2O (1%) + 1ml Sodium potassium tartarate (2%) + 98 ml 
2% Na2CO3 in 0.1N NaOH. 
Solution B: Folin Ciocalteu reagent and distilled water was mixed in 1:1 ratio just before 
use. 
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Procedure  
The animals were sacrificed after treatment by euthanasia. Liver was isolated and 
washed with normal saline. The isolated liver was homogenized in 0.01 M Tris HCL. 
0.01 ml of tissue homogenate (30%) was diluted to 1.2 ml and mixed with 6ml of 
solution A. The mixture was incubated at room temperature for 10 min and added 0.3 ml 
solution B. Mixed well immediately and kept at room temperature for 30 min. Optical 
density was measured at 750 nm. The amount of protein was calculated from the 
standard curve of Bovine Serum Albumin. 
5.4.6. HISTOPATHOLOGICAL STUDIES 
           The liver from all groups were removed rapidly, and thoroughly rinsed with ice-
cold saline. After 24 h of fixation followed by embedding in a paraffin block, it was cut 
into sections of 5 micron onto a glass slide and stained with hematoxylin-eosin for 
histological assessment of the tissue. Sections of liver were examined by light 
microscope at 10 and 40 X magnification. 
5.4.7. SCREENING OF ANTI INFLAMMATORY ACTIVITY  
Experimental methods: 
Anti-inflammatory activity was assessed by carrageenan, histamine and Serotonin 
induced rat paw oedema methods 
5.4.7.1. CARRAGEENAN INDUCED PAW OEDEMA IN RATS 
Experimental design 
Sprague Dawley rats weighed around 120-200g were used for the study. Rats were 
divided into five groups of 6 animals each. 
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Table: 2 Experimental design for carrageenan induced paw oedema 
 
GROUPS TREATMENT 
Group I Carrageenan 1%w/v (0.1 ml, sub plantar ) 
Group II Diclofenac(5 mg/kg) i.p 
Group III GNP (30 mg/kg) 
Group IV GNP (60 mg/kg) 
Group V GCS(60 µg/100 g) 
 
Procedure 
[73-76] 
The rats were divided into five groups of six animals each. The group I was treated with 
freshly prepared 0.1 ml carrageenan, group II was treated with Diclofenac (5 mg/kg) i.p, 
group III and IV were treated with GNP 30 mg/kg and 60 mg/kg  respectively. The group 
V treated with GCS (60 µg/100 gm). Treatments were given 30 min before the 
administration of carrageenan. The rats were then challenged with injection of 0.1 ml of 
1%w/v solution of Carrageenan into the sub plantar region of left paw. The paw was 
marked with ink at the level of lateral malleolus. The paw volume was measured before 
(0 h) and after carrageenan injection at 1, 2, 3, 4, 5 and 6 h by volume displacement 
method using Plethysmometer. The difference of average values between treated animals 
and control group is calculated for each time interval and evaluated statistically. The 
percentage inhibition (PI) of paw edema was calculated by using the following formula; 
Percentage of edema inhibition = {(Vc –Vt)/Vc} × 100 
Vc- Volume of paw oedema in control group.  
Vt- Volume of paw oedema in treated groups. 
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5.4.7.2. HISTAMINE INDUCED RAT PAW OEDEMA 
Experimental design 
Sprague Dawley rats were divided into five groups of 6 animals each. 
Table: 3 Experimental design for histamine induced paw oedema 
GROUPS TREATMENT 
Group I 
0.1 ml of freshly prepared histamine 
(1%) 
Group II Indomethacin (10 mg/kg) i.p 
Group III GNP (30 mg/kg) 
Group IV GNP (60 mg/kg) 
Group V GCS (60 µg/100 g) 
 
Procedure 
[77] 
30 min after the drug treatment, inflammation was induced by injection of freshly 
prepared histamine (0.1 ml) in normal saline underneath the plantar tissue of the  
right hind paw of rats. Paw volume was measured using a plethysmometer before 
histamine administration and at 1, 2, and 3 h after histamine injection. The percentage 
inhibition (PI) of paw oedema was calculated by using the following formula; 
Percentage of edema inhibition = {(Vc –Vt)/Vc} × 100 
Vc- Volume of paw edema in control group.  
Vt- Volume of paw edema in treated groups. 
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5.4.7.3. SEROTONIN INDUCED RAT PAW OEDEMA 
Experimental design 
Sprague Dawley rats were divided into five groups of 6 animals each. 
Table: 4 Experimental design for serotonin induced paw oedema 
GROUPS 
TREATMENT 
 
Group I 
0.1 ml of freshly prepared Serotonin (1%) 
 
Group II 
Indomethacin (10 mg/kg) i.p 
 
Group III GNP (30 mg/kg) 
Group IV GNP (60 mg/kg) 
Group V     GCS (60 µg/100 g) 
 
Procedure 
[78]
 
30 min after the drug treatment, inflammation was induced by injection of 0.1 ml of 
freshly prepared serotonin (1%) in normal saline underneath the plantar tissue of the 
right hind paw of rats. Paw volume, measured using a plethysmometer before serotonin 
administration and at 1, 2, and 3 h after histamine injection. The percentage inhibition 
(PI) of paw edema was calculated by using the following formula; 
Percentage of edema inhibition = {(Vc –Vt)/Vc} × 100 
Vc- Volume of paw edema in control group.  
Vt- Volume of paw edema in treated groups. 
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5.5. STATISTICAL ANALYSIS  
Data were analyzed by one way ANOVA followed by Dunnetts’s/Tukey’s multiple 
comparison tests using Graphpad 5.0 software. The values were expressed as 
Mean±SEM. 
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6. RESULTS 
6.1. Qualitative analysis of GNP and GOLD Colloid solution 
 6.1.1.  SEM image and XRD value of GOLD NANOPARTICLES 
 
 
 
 
 
 
 
 
Figure. 3 A) GNP were  imaged by SEM(left) and by EDS –SEM(right), which shows  
the shape and size of the particles, and the elemental  composition, respectively. 
B) A graph shows the mean size of the GNP by DLS. 
C) A graph shows the XRD pattern of GNP in comparison to gold and the size of 
individual particles is indicated. 
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6.1.2. SEM images and XRD values of GOLD COLLOID SOLUTION 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 4 A) The graph shows the LSPR band corresponding to gold colloid 
solution. 
B) Gold colloid solution were imaged by SEM (left) and by EDS–SEM (right), 
which shows the shape and size of the particles and the elemental composition 
respectively. 
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Table: 5 ELEMENTAL COMPOSITIONS OF GOLD NANOPARTICLES 
  
 
 
 
 
 
 
 
 
 
 
 
 
Table: 6 ELEMENTAL COMPOSITION OF COLLOIDAL GOLD 
 
Elements Concentration (ppm) 
Gold (Au) 89.6 
Mg 0.273 
Ca 1.16 
Na 20.9 
Si 2.69 
 
 
6.1.3. DLS (Dynamic light scattering) 
 
 Average size of Gold nanoparticles- 4.4 nm 
 Average size of Colloidal gold- 31 nm 
 
 
Elements Concentration  % 
Gold  (Au) 56.88 
Mg 1.8 
Ca 1.4 
Fe 0.29 
Si 0.29 
Trace Elements 
Mn 0.037 
Ni 0.02 
As 0.15 
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6.2. MTT ASSAY 
Table: 7 Cytotoxic activity of GNP and GCS in HeLa cell line 
Compound Cell line 
Concentration 
(µL) 
% Cell Growth 
 
 
            
 
 
             GNP 
 
 
            
 
 
             HeLa 
12.5 100.8065 
25 100.1241 
50 99.6898 
100          94.4789 
200 83.4987 
 
 
        
 
           
             GCS 
 
 
          
 
 
             HeLa 
12.5 101.1166 
25 99.9379 
50 99.5037 
100 94.6029 
200 89.2059 
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Figure: 5 Graphical representation of Cytotoxic activity of GNP in HeLa Cell line 
 
 
 
 
    Figure: 6 Graphical representation of Cytotoxic activity of GCS in HeLa cell line 
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          Figure: 7 Pictoral view of Cytotoxic activity of GNP in HeLa Cell line 
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          Figure: 8    Pictoral view of Cytotoxic activity of GCS in HeLa Cell line 
 
 
                                   
                       12.5 µL                                                                             25 µL                                                                          
           25 
                      
                                                                     50 µL                                                                          
                                                                               
                  100 µL                                                                              200 µL  
 
                                                                         
 
            
               
 
 
RESULTS 
 
Department of Pharmacology  Page 54 
 
 6.3.  HCC DEVELOPMENT 
                                        
              Normal Control    
                                           
                Standard                                                                         GNP Low dose 
                                                      
          GNP High dose                                                                 Gold Colloid Solution 
                          Figure:  9 Development of Tumor in experimental rats 
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6.4. PHARMACOLOGICAL EVALUATION 
6.4.1. ESTIMATION OF HEMATOLOGICAL PARAMETERS 
Table: 8 Effect of GNP& GCS on the RBC& WBC counts 
 
Groups 
 
Normal Control Standard 
GNP Low 
dose 
GNP High 
dose 
GCS 
RBC 
(1 x 
10
6
cells/mm
3
) 
9.97±0.13 5.29±0.08*** 6.82±0.06*** 8.65±0.13*** 7.83±0.25*** 8.40±0.29*** 
WBC 
(1 x 
10
3
cells/mm
3
) 
5.06±0.12 5.86±0.16*** 6.46±0.14* 3.01±0.09*** 5.36±0.12ns 4.94±0.03*** 
 
***- P<0.001, **- P<0.01, *- P<0.05, ns – Non Significant 
 
Data is expressed as Mean ± SEM (n = 6 animals in each group)  
Analysis of Variance (ANOVA); one way ANOVA followed by Tukey:Compare Test was 
performed. The hepatocellular control group was compared with normal and all other groups 
were compared with hepatocellular control group. The value shows significant at 
P<0.001.  
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              Figure: 10 Estimation of RBC 
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          Figure: 11 Estimation of WBC 
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6.4.2. BODY WEIGHT ANALYSIS 
Table: 9 Effect of the GNP& GCS on the Body weight of the Experimental rats 
Weight 
in 
gram 
Normal Control Standard GNP Low dose GNP  High dose GCS 
Initial 
body 
weight 
209.5±2.2 151.5±2.2*** 143.5±2.2*** 119.7±1.2*** 108.2±1.4*** 125.8±1.7*** 
Final 
body 
weight 
337.5±2.2 287.0±1.5*** 258.0±1.5*** 225.2±1.7*** 200.5±2.3*** 213.5±0.4*** 
                
  ***- P<0.001, **- P<0.01, *- P<0.05, ns – Non Significant 
Data is expressed as Mean ± SEM (n = 6 animals in each group)  
Analysis of Variance (ANOVA); one way ANOVA followed by Tukey:Compare Test 
was performed. The hepatocellular control group was compared with normal and all 
other groups were compared with hepatocellular control group. The value shows 
significant at P< 0.001. 
 
                                    Figure: 12 Estimation of Body weight analysis 
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 6.4.3. LIVER WEIGHT ANALYSIS 
                     Table: 10 Effect of the GNP& GCS  on the Liver weight of the Experimental rats 
Groups Normal Control Standard 
GNP  
Low dose 
GNP 
High dose 
GCS 
Liver 
Weight 
(in gm) 
8.7±0.13 10.7±0.15** 9.4±0.24*** 9.5±0.14** 9.8±0.23* 9.3±0.17*** 
   ***- P<0.001, **- P<0.01, *- P<0.05, ns – Non Significant 
Data is expressed as Mean ± SEM (n = 6 animals in each group)  
Analysis of Variance (ANOVA); one way ANOVA followed by Tukey:Compare Test 
was performed. The hepatocellular control group was compared with normal and all 
other groups were compared with hepatocellular control group. The value shows 
significant at P< 0.001. 
 
                                                            Figure: 13 Liver weight analysis 
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6.4.4. SERUM BIOCHEMICAL PARAMETERS 
    Table: 11 Effect of the GNP& GCS on the Serum biochemical parameter 
 
Groups SGOT(U/L) SGPT(U/L) ALP(U/L) Total 
protein(g/dl) 
Normal 35.18±0.625 39.91±1.151 122.1±0.832 4.058±0.112 
Control 66.67±0.763*** 74.66±2.753*** 143.1±3.537*** 6.33±0.118*** 
Standard 59.33±0.844*** 102.8±1.563** 179.5±3.217*** 5.068±0.118*** 
GNP low dose 63.39±0.420* 125.9±2.957** 165.2±5.048*** 6.964±0.145* 
GNP high dose 61.84±0.649*** 118.0±7.593*** 150.2±3.225ns 7.080±0.120** 
GCS 62.04±0.319*** 121.4±5.318*** 153.9±0.416ns 6.898±0.120*** 
 
   ***- P<0.001, **- P<0.01, *- P<0.05, ns – Non Significant 
Data is expressed as Mean ± SEM (n = 6 animals in each group)  
Analysis of Variance (ANOVA); one way ANOVA followed by Tukey:Compare Test 
was performed. The hepatocellular control group was compared with normal and all 
other groups were compared with hepatocellular control group. The value shows 
significant at P< 0.001. 
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           Figure: 14 Effect of GNP and GCS in serum SGOT level 
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                               Figure: 15 Effect of GNP and GCS in serum SGPT level 
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                                          Figure: 16 Estimation of GNP and GCS in Serum ALP level 
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        Figure: 17 Estimation of GNP and GCS on Serum TOTAL PROTEIN level 
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6.5. ESTIMATION OF HISTOPATHOLOGY 
 
                 Normal                                                                                Control 
                                                    
 Architecture effaced Architecture-Normal 
 Cells-Enlarged, Granularoty-Present                                                              Cells- Unremarkable  
 Cellularity atypia and Mitotic activity-present  
                                         GNP Low dose 
                                                          
                                                                     Liver architecture midly effaced 
                                                                     Cytoplasmic granularity-Present, Nuclei-Enlarged 
                                                                     Few apoptotic bodies -few 
               GNP High dose                                                             Gold Colloid Solution 
                                            
Architecture- preserved                                                                              Architecture- Preserved 
Cytoplasm- Granularity moderately reduced                                      Cytoplasmic granularity-Markedlyreduced                                                       
Nuclei- Normal                                                                                           Nuclei-Normal 
 
                                                Figure: 18 Estimation of histopathology 
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6.6.2. HISTAMINE INDUCED PAW OEDEMA IN RATS 
 
 
Table: 13 Effect of GNP and GCS on Histamine induced paw oedema in rats 
 
Statistical comparison: Values represent mean ± SEM, n=6, statistical analysis was done by 
one way analysis of variation (ANOVA) followed by Tukey:compare test. 
***P<0.001, **P<0.01, *P<0.05 and ns- non significant denote the comparison of treated groups 
with control. 
 
 
 
 
 
 
 
Group TREATMENT 
Mean oedema volume (ml) and % inhibition 
1 hr 2hr 3hr 
I Histamine 1%w/v (0.1ml) 0.0700±0.007 0.1350±0.0155 0.1600±0.016 
II Indomethacin(25mg/kg) 
0.0375±0.006* 
 
46.42% 
0.0550±0.008** 
 
59.25% 
0.0550±0.005*** 
 
65.62% 
III GNP(30mg/kg) 
0.0450±0.006* 
 
35.71% 
0.675±0.006** 
 
50% 
0.0600±0.007** 
 
62.5% 
I GNP(60 mg/kg) 
0.0550±0.006ns 
 
21.42% 
0.0900±0.007* 
 
33.33% 
0.0850±0.005*** 
 
46.87% 
V GCS(60µg/100g)) 
0.0450±0.005* 
 
35.71% 
0.0650±0.008** 
 
51.85% 
0.0575±0.004** 
 
64.06% 
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6.6.3. SEROTONIN INDUCED PAW OEDEMA 
 
Table: 14 Effect of GNP and GCS on serotonin induced paw oedema in rats 
 
Group TREATMENT 
Mean oedema volume (ml) and % inhibition 
1 hr 2hr 3hr 
I serotonin 1%w/v (0.1ml) 0.0775±0.02 0.1100±0.002 0.1375±0.001 
II Indomethacin(25mg/kg) 
0.0605±0.002*** 
 
21.93% 
0.0700±0.0008*** 
 
36.36% 
0.0752±0.001*** 
 
45.30% 
III GNP(30mg/kg) 
0.0615±0.0006*** 
 
20.64% 
0.0750±0.009ns 
 
31.81% 
0.0820±0.0008*** 
 
       40.36% 
I V GNP(60 mg/kg) 
0.0620±0.001** 
 
20% 
0.0775±0.006** 
 
29.54% 
0.0950±0.001** 
 
30.90% 
V      GCS(60µg/100g)) 
0.0650±0.0008** 
 
16.12% 
0.0850±0.0008* 
 
22.72% 
       0.1±0.003** 
 
           27.27% 
 
Statistical comparison: Values represent mean ± SEM, n=6, statistical analysis was done by 
one way analysis of variation (ANOVA) followed by Tukey:compare test. 
***P<0.001, **P<0.01, *P<0.05 and ns- non significant denote the comparison of treated groups 
with control. 
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7. DISCUSSION 
FESEM revealed the structure of the Gold nanoparticles and Gold colloid 
solution. It showed nano-scale structure of gold nano particles. When reduced to this 
size any medicinal compound gains additional properties such as better 
bioavailability, lower dose requirement, target specificity etc. 
Dynamic light scattering (DLS) measures the particle size of Gold 
nanoparticles and Gold colloid solution. The particle size of Gold nanoparticles and 
Gold colloid solution shows 4.4 nm and 31 nm respectively. 
The XRD pattern of Gold nanoparticles and Gold colloid solution reflects gold 
metal as the major phase along with certain impurities. The EDS reports of Gold 
nanoparticles and Gold colloid solution show peaks for Mg, Ca, and Si these elements 
are common to found in both preparations. 
   The in vitro anti-cancer activities of GNP and GCS in MTT assay 
were determined by using HeLa cell lines. The MTT assay is based on metabolic 
reduction of dye MTT to water soluble blue formazan complex is directly 
proportional to number of visible cells Nano particles did not be show any toxic effect 
in isolated cells. As per reported by many other studies, 
[79]
 gold nanoparticles enters 
the cell by (presumably) endocytosis, did not induce any toxicity, and reduce the level 
of reactive oxygen species. Toxicity of gold nanoparticles (spheres, 10 nm in 
diameter) when studied on dendritic cells (part of the human immune system, which 
process and present antigens on their surfaces for other cells) nanoparticles were 
found to be non-cytotoxic, and it did not induce activation or didn’t change phenotype 
of the cells. 
[80] 
. In the present study ,in  in vitro condition GNP and GCS do not 
produce any cytotoxic effect.
 
  The formation of reactive oxygen species (ROS) is deceptive during the 
metabolic biotransformation of DEN resulting in oxidative stress. Oxidative stress 
leads to carcinogenesis by several mechanisms including the damage of integrity of 
various biomolecules including DNA, lipid and protein, change in intracellular 
signaling pathways and even changes in gene expression. Lipid peroxidation (LPO)  
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may possibly also result in several changes, including structural and functional 
membrane modifications, protein oxidation and generation of oxidation products such 
as acrolein, crotonaldehyde, malondialdehyde (MDA) and 4-hydroxy-2-nonenal 
(HNE), which are considered strong carcinogens. 
[81]
 
In the current study, a significant reduction in the body weight of the diseased 
animals was observed when compared with the normal control. The GNP and GCS 
treated group has showed an average increased body weight that was comparable with 
the standard group as well as the normal control group. The GNP and GCS group has 
shown increased body weight than the diseased control group. 
Increase in liver weight was observed for the disease control group and the 
marked reduction of weight was observable in both GNP and GCS treated groups. 
Alterations were seen in the haematological parameters in HCC. The disease 
control group has shown a significant reduction in RBC and elevation of WBC. The 
GNP and GCS group has shown a significant increase of RBC. The control group 
showed significant increase in WBC count while the GNP and GCS treated group 
showed moderate reduction in WBC.  
Serum biochemical parameters show an altered pattern in the cancerous 
condition. The escalation in the activities of plasma ALP, SGOT, SGPT indicated that 
DEN may prompt hepatic dysfunction. The enzymes directly associated with the 
conversion of amino acids to keto acids are AST and ALT, and are proved to be 
increased in the HCC condition. 
[82]
 All the biochemical parameters were significantly 
elevated in the disease control group. GNP and GCS treatment group was also very 
effective in normalizing the SGPT, SGOT level, but only a moderately significant 
reduction was shown for the other parameters. 
 Total protein present in the liver tissue of disease control group was reduced 
due to the cancerous condition. But in the GNP and GCS treated group there was a 
significant increase in the protein levels compared to disease control and no 
noticeable difference when compared to the normal control.   
 The results obtained from the current study demonstrate that the GNP and 
GCS groups showed higher shielding in DEN induced HCC rat model at 30mg/kg.  
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The anti-inflammatory activity of the GNP and GCS was evaluated by three 
experimental models, i.e., carrageenan-induced paw oedema, Histamine induced paw 
oedema and serotonin induced paw oedema. Carrageenan induced paw oedema model 
is used to screen the anti-inflammatory activity of a drug in the acute phase of 
inflammation. Sub plantar injection of carrageenan into the rat paw produces plasma 
extravasation and the inflammation characterized by increased tissue water and 
plasma protein exudation with neutrophil extravasation and metabolism of 
arachidonic acid by both cyclooxygenase and lipo oxygenase enzyme pathways. 
Oedema induced by carrageenan is a biphasic event. The first phase (1 hour) involves 
the release of serotonin and histamine and the second phase (> 1 hour) is mediated by 
prostaglandins. The mean oedema volume and percentage inhibition was calculated 
for 6 hours.  
In carrageenan induced paw oedema, the percentage inhibition of GNP 
(30mg/kg) was found to be 11.57%, 25.62%, 30.03%, 33.33%, 32.41% and 30.70%. 
at 1 h to 6 h respectively, GNP (60 mg/kg) was found to be 23.15%, 33.12%, 37.88%, 
45.51%, 44.29% and 43.66% at 1 h to 6 h respectively. GCS (60 µg/100 g) was found 
to be 18.52%, 28.72%, 35.68%, 39.87%, 38.23% and 38.02% at 1 h to 6 h 
respectively.  
The highest percentage inhibition for GNP (30 mg/kg) was found to be at 4
th 
h 
(33.33%), GNP (60 mg/kg) at 4
th
 h (45.51%) and GCS (60 µg/100 g) at 4
th
 h 
(39.87%). 
A significant anti oedematous activity of both doses of GNP (30 mg/kg and 60 
mg/kg) and GCS (60 µg/100 g) was observed during the second phase of 
inflammation, indicating the inhibition of prostaglandin release. The maximal 
percentage inhibition was observed at 3
rd
 and 4
th
 hours.  
 It may be concluded that GNP (60mg/kg) significantly suppressed 45.51 % 
paw oedema from 4h shows higher activity. So it might be blocking prostaglandin and 
/or bradykinin release rather than histamine and/or serotonin. Diclofenac also has 
shown similar effect only at second phase. 
The two doses of formulation GNP  (30 mg/kg ),GNP(60 mg/kg) and GCS 
(60µg/100 g) exerted a significant inhibition of 35.71%, 21.42% and 35.71%  at 1 h 
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and 50%, 33.33% and 51.85% at 2 h  and 62.5%, 46.87% and 64.06%  at 3 h 
respectively in the histamine induced rat paw oedema model. It was observed that the 
GNP and GCS was capable of inhibiting oedema induced by histamine and the 
effectiveness for suppression of oedema might be due to the ability of  GNP and GCS  
to inhibit the synthesis, release or action of histamine involved in the inflammation. 
GCS (60 µg/100 g) significantly suppressed 64.06% paw oedema at 3 h shows higher 
activity. 
The two doses of formulation GNP  (30 mg/kg and 60 mg/kg) and GCS 
(60µg/100 g) exerted a significant inhibition of 20.64%, 20% and 16.12%  at 1 h and 
31.81%, 29.54% and 22.72% at 2 h  and 40.36%, 30.90% and 27.27%  at 3 h 
respectively in the serotonin induced rat paw oedema model . It was observed that the 
GNP and GCS were capable of inhibiting oedema induced by serotonin. GNP 
(30mg/kg) significantly suppressed 40.36% at 3 h shows higher activity. 
Molecular and cellular pathways shows link with inflammation and cancer. 
Schematically, there are two pathways: intrinsic and extrinsic. In the extrinsic 
pathway, inflammatory conditions promote cancer development. Inflammatory 
mediators destabilize the cancer cell genome which accelerates the somatic evolution 
of cancer. 
COX-2, a key isoenzyme in conversion of arachidonic acid to prostaglandins 
is inducible by various agents such as growth factors and tumor promoters and 
frequently over expressed in various tumors. The potency of COX-2 inhibitors in vivo 
can be attributed to the inhibition of the enzyme in the tumour as well as in stromal 
cells, resulting in anti-proliferative and pro-apoptopic actions within the tumour, and 
anti-angiogenic and pro-immune surveillance activities in endothelial and myeloid 
cells. The combination of COX-2 inhibitor with standard cancer chemotherapeutic 
and/or radiation may provide additional therapeutic paradigms in the treatment of 
various human cancers. Hence, the cyclooxygenase-2 (COX-2) has a role in 
hepatocarcinogenesis, as selective COX-2 inhibitors (COXIBs) show antiproliferative 
and pro-apoptotic effects in human HCC cell lines. 
[83]
 
Besides this transcription factor, essential in regulating inflammation and 
cancer development, an inflammatory microenvironment inhabiting various 
inflammatory cells and a network of signaling molecules are indispensable for the 
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malignant progression of transformed cells, which is attributed to the mutagenic 
predisposition of persistent infection fighting agents at sites of chronic inflammation. 
[81
 The contribution of COX-2 is being related to its abilities to increase the 
production of prostaglandins, convert procarcinogens in to carcinogen, inhibit 
apoptosis promote angiogenesis modulate inflammation and immune function and 
increase tumor cell invasiveness. COX-2 inhibitors show marked inhibition of tumor 
growth and metastasis. 
[84] 
 The potential of the compound to inhibit cyclooxygenase enzyme drive us to 
the assumption that the anticancer activity of GNP and GCS may be associated with 
the inhibition of COX-2 enzyme. Further studies are required to confirm this.   
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8. CONCLUSION 
In the present study GNP (Thangaparpam) and GCS (Gold colloid solution) were 
evaluated for its anti-inflammatory and anti cancer activities. Qualitative analysis of 
GNP and GCS performed by various methods like, FESEM, DLS, XRD and EDS 
showed differences in particle size, surface property, and elemental composition. GNP 
and GCS showed significant anti-inflammatory activity in carrageenan, histamine and 
serotonin induced paw edema methods compared to the respective standard drugs. On 
the other hand, both the compounds showed remarkable anti cancer activity in the in 
vitro and in vivo models (ie,MTT assay and DEN induced HCC model respectively) 
Persistent inflammation is known to promote and exacerbate malignancy. The 
inflammatory mediators, some of that are direct mutagens, also directly or indirectly 
down regulate DNA repair pathways and cell cycle checkpoints, thus destabilizing 
cancer cell genome and contributing to the accumulation of random genetic alterations 
which in turn accelerate the somatic evolution of cancer. Hepatocellular carcinoma 
(HCC), is a clear example of inflammation-related cancer as more than 90 % of HCCs 
arise in the context of hepatic injury and inflammation. This is suggestive for the 
mechanism behind remarkable anticancer activity obtained for GNP and GCS in the 
present study. Already well known for its anti inflammatory activity, these formulations 
can further evolve as an potent anticancer agent or  can be used in combination with 
other anticancer drugs with the goal of improving the efficiency of the anti-cancer 
protocol. Further studies are required to validate the anticancer activity against HCC and 
to evaluate its effectiveness in other types of cancer. 
 
 
  
 
ABSTRACT 
Aim: This study aims to elucidate the in vivo, in vitro anti-cancer and anti-inflammatory 
effects of GNP and GCS.   
Methodology: The qualitative analysis of GNP and GCS were performed by different 
methods, i. e.  FESEM, DLS, XRD, EDS. 
In vitro anticancer study performed by MTT assay. The cytotoxic activity of GNP 
and GCS at different concentrations (12.5, 25, 50, 100 and 200 µL) were determined 
using HeLa cell line. 
 In in vivo anticancer study, initiation of HCC was done by single i.p injection of 
DEN at a dose of 200mg/kg. The GNP (30 mg/kg, 60 mg/kg) and GCS (60 µg/100 kg) 
received treatment for 90 days after 7 days of development of HCC and continued for 
entire study period, whereas the other two groups given normal saline and 5-flurouracil 
(20mg/kg) i.p. 
      The anti-inflammatory activity of the GNP (30 mg/kg, 60 mg/kg) and GCS (60          
µg/100kg) were evaluated by three experimental models, i.e. Carrageenan-induced paw 
edema model, in which diclofenac (5mg/kg) was used as standard. Whereas in histamine 
and serotonin induced paw edema models indomethacin (10mg/kg) was the standard. 
Results: The results showed that the injection DEN lead to the development of liver 
tumors in rats.  Significant elevation of the serum biochemical parameters like ALP, 
SGOT, SGPT and Total protein. The results exhibited that GNP and GCS treatment 
group have excellent shielding against HCC and displayed all the parameters in near 
normal range. GNP and GCS also exhibited significant anti-inflammatory activity which 
was evident with reduction in mean paw oedema volume in carrageenan, histamine and 
serotonin induced inflammatory models. 
Conclusion: The results revealed that the GNP and GCS possess significant inhibition of 
paw oedema in all the three inflammatory models.These formulations can further evolve 
as an potent anticancer agent or  can be used in combination with other anticancer drugs 
with the goal of improving the efficiency of the anti-cancer protocol. Further studies are 
required to validate the anticancer activity against HCC and to evaluate its effectiveness 
in other types of cancer. 
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